Fifth Third Wealth Advisors LLC Vertex Pharmaceuticals Inc Transaction History
Fifth Third Wealth Advisors LLC
- $1.63 Trillion
- Q3 2024
A detailed history of Fifth Third Wealth Advisors LLC transactions in Vertex Pharmaceuticals Inc stock. As of the latest transaction made, Fifth Third Wealth Advisors LLC holds 997 shares of VRTX stock, worth $408,331. This represents 0.03% of its overall portfolio holdings.
Number of Shares
997
Previous 508
96.26%
Holding current value
$408,331
Previous $238 Million
94.74%
% of portfolio
0.03%
Previous 0.02%
Shares
2 transactions
Others Institutions Holding VRTX
# of Institutions
1,725Shares Held
221MCall Options Held
1.58MPut Options Held
1.36M-
Capital World Investors Los Angeles, CA26.8MShares$11 Billion1.99% of portfolio
-
Vanguard Group Inc Valley Forge, PA23.2MShares$9.49 Billion0.2% of portfolio
-
Black Rock Inc. New York, NY21.3MShares$8.73 Billion0.23% of portfolio
-
State Street Corp Boston, MA11.8MShares$4.84 Billion0.23% of portfolio
-
Capital Research Global Investors Los Angeles, CA9MShares$3.69 Billion0.9% of portfolio
About VERTEX PHARMACEUTICALS INC
- Ticker VRTX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 256,691,008
- Market Cap $105B
- Description
- Vertex Pharmaceuticals Incorporated, a biotechnology company, engages in developing and commercializing therapies for treating cystic fibrosis. The company markets SYMDEKO/SYMKEVI, ORKAMBI, and KALYDECO to treat patients with cystic fibrosis who have specific mutations in their cystic fibrosis transmembrane conductance regulator gene; and TRIKAF...